Lee Ainslie Maverick Capital
Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$467M |
| 2 |
Insmed
INSM
|
+$260M |
| 3 |
DPC
DPC Holdings PLC
DPC
|
+$250M |
| 4 |
GFL Environmental
GFL
|
+$240M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$410M |
| 2 |
Applied Materials
AMAT
|
+$400M |
| 3 |
Argan
AGX
|
+$253M |
| 4 |
TSMC
TSM
|
+$213M |
| 5 |
Linde
LIN
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.07% |
| 2 | Healthcare | 17.67% |
| 3 | Financials | 10.05% |
| 4 | Industrials | 9.89% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Expedia Group
EXPE
$38.6B
| – | – |
-9,513
| Closed | -$2.2M |
|
227
FedEx
FDX
$76.9B
| – | – |
-1,980
| Closed | -$705K |
|
|
FITB
228
Fifth Third Bancorp
FITB
$49.7B
| – | – |
-22,341
| Closed | -$1.04M |
|
229
Five Below
FIVE
$13.8B
| – | – |
-3,661
| Closed | -$836K |
|
230
Freshpet
FRPT
$3.55B
| – | – |
-34,509
| Closed | -$2.03M |
|
231
Globe Life
GL
$13.1B
| – | – |
-11,081
| Closed | -$1.54M |
|
232
Globus Medical
GMED
$11.7B
| – | – |
-15,660
| Closed | -$1.35M |
|
233
Gates Industrial Corp
GTES
$6.56B
| – | – |
-37,398
| Closed | -$846K |
|
234
Huntington Bancshares
HBAN
$34.4B
| – | – |
-83,182
| Closed | -$1.3M |
|
235
Hudbay
HBM
$13.4B
| – | – |
-59,037
| Closed | -$1.23M |
|
236
Helix Energy Solutions
HLX
$1.53B
| – | – |
-75,723
| Closed | -$749K |
|
237
Hormel Foods
HRL
$13.1B
| – | – |
-171,063
| Closed | -$3.87M |
|
238
H&R Block
HRB
$6.62B
| – | – |
-19,943
| Closed | -$633K |
|
239
Huntsman Corp
HUN
$1.75B
| – | – |
-65,283
| Closed | -$869K |
|
240
Integra LifeSciences
IART
$1.3B
| – | – |
-72,108
| Closed | -$679K |
|
241
Icon
ICLR
$13.3B
| – | – |
-13,887
| Closed | -$1.54M |
|
242
Intuit
INTU
$100B
| – | – |
-1,564
| Closed | -$676K |
|
243
Interparfums
IPAR
$3.7B
| – | – |
-56,734
| Closed | -$5.15M |
|
244
Integer Holdings
ITGR
$4.26B
| – | – |
-14,051
| Closed | -$1.24M |
|
245
Janus International
JBI
$697M
| – | – |
-99,996
| Closed | -$515K |
|
246
James Hardie Industries
JHX
$17.7B
| – | – |
-35,531
| Closed | -$673K |
|
247
KBR
KBR
$4.86B
| – | – |
-32,606
| Closed | -$1.2M |
|
248
Kimberly-Clark
KMB
$36.4B
| – | – |
-19,028
| Closed | -$1.84M |
|
249
Knight Transportation
KNX
$11.7B
| – | – |
-10,609
| Closed | -$611K |
|
250
Kroger
KR
$35.5B
| – | – |
-6,359
| Closed | -$460K |
|
Similar funds
Lee Ainslie's Q2 2026 Portfolio in Review
As of Q2 2026, Lee Ainslie held 327 positions worth $11.3B, up 31% from $8.67B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Lee Ainslie deployed $688M of net new capital in Q2 2026, opening 86 new positions and adding to 49 existing holdings. Its largest new stake was Meta Platforms (Facebook): 764,041 shares worth $430M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was ASML, an estimated $410M trimmed.
- Lee Ainslie's largest Q2 2026 buy was Meta Platforms (Facebook): 764,041 shares worth $430M.
- Lee Ainslie added most to GFL Environmental in Q2 2026, an estimated $240M increase.
- Lee Ainslie's biggest Q2 2026 reduction was ASML, cutting an estimated $410M.
- Lee Ainslie fully exited Argan in Q2 2026, selling an estimated $253M.
- Lee Ainslie's ten largest holdings make up 43% of its $11.3B portfolio in Q2 2026.
- Lee Ainslie opened 86 new positions and closed 148 in Q2 2026.
- Lee Ainslie's portfolio value rose 31% quarter-over-quarter to $11.3B.
Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.